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Abstract
We describe a supervised prediction method for diagnosis of acute myeloid leukemia (AML) from patient samples based on
flow cytometry measurements. We use a data driven approach with machine learning methods to train a computational
model that takes in flow cytometry measurements from a single patient and gives a confidence score of the patient being
AML-positive. Our solution is based on an ‘1 regularized logistic regression model that aggregates AML test statistics
calculated from individual test tubes with different cell populations and fluorescent markers. The model construction is
entirely data driven and no prior biological knowledge is used. The described solution scored a 100% classification accuracy
in the DREAM6/FlowCAP2 Molecular Classification of Acute Myeloid Leukaemia Challenge against a golden standard
consisting of 20 AML-positive and 160 healthy patients. Here we perform a more extensive validation of the prediction
model performance and further improve and simplify our original method showing that statistically equal results can be
obtained by using simple average marker intensities as features in the logistic regression model. In addition to the logistic
regression based model, we also present other classification models and compare their performance quantitatively. The key
benefit in our prediction method compared to other solutions with similar performance is that our model only uses a small
fraction of the flow cytometry measurements making our solution highly economical.
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Introduction
Leukemias are a common malignancy of blood cells emerging
from different cell types [1]. For example, acute myeloid leukemia
(AML), which is the focus of this work, emerges during myeloid
differentiation. However, the traditional classification of leukemias
relies predominantly on morphologic and cytochemical features of
the tumor cells rather than the developmental origin of the
malignancy [2].
Blood cancers are diagnosed with various techniques including
features from morphologic, cytochemic, cytogenetic, and flow
cytometry. While morphologic, cytochemic, and cytogenetic
analysis include standard pathological stainings that lead to low
dimensional data that can typically be interpreted directly under
microscope, analysis of flow cytometric data includes interpreta-
tion of more complex high dimensional data distributions and,
thus, computer assisted decision systems are needed to support
diagnosis decision making. [3].
Flow cytometry can be used to analyze a large number of
individual cells and, thus, is well suited to detect, e.g., cells that
express particular cancer related surface markers from blood
samples. In the measurement process, cells are labeled with
fluorescent dye. The dye can be delivered, e.g., by specific antigen
binding antibodies. Fluorescent labeled cells are guided through a
laser beam and the resulting fluorescence and scatter parameters,
typically forward and side scatter, are detected by photo detector.
Forward scatter is informative of the cell size and side scatter
corresponds to cell granularity. These control measures are used to
make sure the data from different experiments are comparable by
‘‘gating’’ or selecting the cells with corresponding features for
subsequent analysis. With modern instruments several lasers and
dyes with different wave lengths can be used and, thus, multiple
measurements can be done from a single cell in parallel. [3,4].
In this paper, we introduce a supervised prediction method for
diagnosis of AML from flow cytometry data. Our prediction
model is data driven in the sense that no prior biological
knowledge is used in the model construction, e.g., in feature
selection. There are two stages in the processing: First, for each
individual flow cytometry tube with a different combination of
measured fluorescence markers, a feature generation and dimen-
sion reduction steps are applied after which a probability density
model is learned from the training data for both AML-positive and
healthy patients. Second, error scores calculated between the test
patient’s distribution and the learned distributions from each tube
are aggregated by a logistic regression model that predicts the final
confidence score of the patient being AML-positive. The
parameters of the logistic regression model are estimated from
the training data using ‘1 regularization, which works as an
embedded feature selector and results in a sparse model where
only a part of the tubes are needed in making the diagnosis. The
feature selection is our key contribution: Our prediction model
requires significantly fewer measurements than the alternative
approaches.
The prediction model presented in this paper is based on our
submission to the DREAM6/FlowCAP2 Molecular Classification
of Acute Myeloid Leukaemia Challenge (DREAM6 AML
Challenge) held in conjunction with the Dialogue for Reverse
Engineering Assessments and Methods (DREAM6) conference
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organized in 2011. In the challenge evaluation, 8 of the 17
participating teams, including our solution, achieved 100%
prediction result in terms of ranking based error metrics (e.g.,
precision and recall) when tested against the hidden test data
consisting of measurements from 20 AML-positive and 160
healthy patients. Other well performing models were based, e.g.,
on Kullback-Leibler divergence based distance between histogram
estimated densities (http://www.ehu.es/biologiacomputacional/
team21_vilar) and Learning Vector Quantization (LVQ) with moment
based features by Biehl et al. [5]. Further description about the
challenge results and joint algorithm descriptions from the
participating teams is published in [6].
The fact that about half of the participating teams achieved a
perfect result suggests that the challenge test data was not
particularly difficult to classify. However, the training data contains
a couple of ‘‘difficult patients’’ that were misclassified by many
teams. This works as a motivation for this paper, where we
combine the challenge training and test sets and their golden
standards to get a larger set of 43 AML-positive and 316 healthy
patients. Moreover, due to the high accuracy of several methods,
we will concentrate on finding the simplest model that is able to reach
a comparable performance. The classifiers are compared using
cross-validation (CV) with area (AUC) under the operating
characteristics (ROC) curve and the precision-recall (PR) curve
as well as confusion matrices.
The performance of our predictor is compared against the
methods by Vilar and by Biehl et al. [5]. Both solutions achieved a
100% prediction accuracy in the DREAM6 AML Challenge.
Further, Vilar had the highest correlation between the predictor
output and the ground truth. Notice that the Pearson correlation
used in the challenge evaluation is not a very good evaluation
metric (although probably the only applicable one in the
challenge) because it depends, e.g., on the link function of the
prediction model, which is irrelevant from the classification point
of view.
Further in this paper, an improved prediction method is
proposed that simplifies our original method without decreasing its
performance. In addition, we apply a simple linear discriminant
analysis (LDA) on the average intensities of each fluorescent
marker and use it as a baseline reference method. Finally, we use
all the data for training and analyze the created model revealing
useful information from the viewpoint of medical AML diagnosis.
Especially the coefficients of the sparse logistic regression model
are inspected in order to find out, which of the flow cytometry
tubes and markers are actually needed in the diagnosis and which
can be discarded.
Materials and Methods
The following sections give a description of the flow cytometry
data that we use in the experiments. In addition, we give a brief
overview and a block diagram of the method that we use to
automatically diagnose AML followed by a detailed algorithm
description. Finally, we introduce the other models, which we use
for comparison in the experiments.
Flow Cytometry Data
We use the DREAM6 AML prediction challenge data set which
is available at the challenge website (http://www.the-dream-
project.org/challenges). The data set consists of flow cytometry
measurements taken from 43 AML-positive and 316 AML-
negative patients. The original challenge training set is a subset
of these consisting of 179 patients (23 AML-positive and 156
healthy ones).
Flow cytometry is used for quantification of expression of
different protein markers in the patient’s blood or bone marrow
sample. A limited number of protein markers can be measured for
cells in one sample tube (aliquot). The challenge data contains
seven tubes containing 6764 to 49370 events, i.e., cells. A different
combination of five different markers is measured from each tube.
These marker combinations (FL1–FL5) have been listed in
Table 1. Each marker is only present in one of the tubes except
for marker CD45, which is included in all of the tubes. In addition
to fluorescence intensities, forward and side scatter readings are
provided for each tube. Tube number eight is a control tube with
non-specific-binding antibodies. We don’t use this tube for
prediction purposes.
Both raw and preprocessed flow cytometry data are provided in
the challenge website. As the original experimental setup has been
designed by the the contest organizers for a large benchmark study
[6], we rely that the setup is meaningful and that the provided data
has been processed according to the standards of the field. For
prediction, we use the preprocessed data, which is compensated/
translated using the method described in [7]. Briefly, the
preprocessed data contains the forward scatter in linear scale,
side scatter in logarithmic scale, and the fluorescence intensities for
the five channels described in Table 1 in logarithmic scale. As an
alternative to the preprocessed data, we experimented with a
regression based preprocessing method [8] directly applied for the
raw data. However, no improvement was gained in the results.
Thus, all results presented below are for the preprocessed contest
data which is available in CSV format from the contest web site.
Prediction Model Overview
The flow cytometry data we are using consists of seven tubes
with thousands of cells each. All the cells originate from a single
patient who is either AML-positive or healthy. Instead of trying to
classify each individual cell as AML-positive or healthy, the key
strategy is to consider the cell populations as whole and, finally,
fuse together the information that each tube independently
provides.
A detailed description of the structure of our prediction model
will be given in the forthcoming sections. For an overview, see
Figure 1. As a starting point, we have a feature generation step
where the dimensionality of the tube data is increased by
generating some artificial features. This is done in order to avoid
Table 1. Fluorescence markers provided in DREAM6 AML
prediction challenge data.
FL1 FL2 FL3 FL4 FL5
Tube 1 IgG1-FITC IgG1-PE CD45-ECD IgG1-PC5 IgG1-PC7
Tube 2 Kappa-FIT Lambda-PE CD45-ECD CD19-PC5 CD20-PC7
Tube 3 CD7-FITC CD4-PE CD45-ECD CD8-PC5 CD2-PC7
Tube 4 CD15-FITC CD13-PE CD45-ECD CD16-PC5 CD56-PC7
Tube 5 CD14-FITC CD11c-PE CD45-ECD CD64-PC5 CD33-PC7
Tube 6 HLA-DR-FITC CD117-PE CD45-ECD CD34-PC5 CD38-PC7
Tube 7 CD5-FITC CD19-PE CD45-ECD CD3-PC5 CD10-PC7
Tube 8 N/A N/A N/A N/A N/A
Seven tubes (and one unspecified control tube) with different fluorescence
markers (FL1–FL5) are provided in the DREAM6 AML prediction challenge data
set. (Table from challenge web site: http://www.the-dream-project.org/
challenges/dream6flowcap2-molecular-classification- acute-myeloid-leukaemia-
challenge).
doi:10.1371/journal.pone.0072932.t001
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the limitations of the subsequent linear model, thus, improving the
class separation. Next, the resulting 84-dimensional data is
projected to 1-d by using Fisher’s linear discriminant analysis
(LDA) that maximizes the separability between the AML-positive
samples and the healthy ones. We then compare the empirical
cumulative distribution function (EDF) of the tube data with
corresponding trained EDFs of both AML-positive and healthy
populations by using a simple mean squared error metric. This
results in two EDF similarity measures per tube.
For the higher level aggregation of individual tubes we use
logistic regression. The parameters of the logistic regression model
are estimated using a method that penalizes the coefficient
magnitudes using an ‘1 penalty [9]. This results in a sparse model
where only a few tubes are needed in evaluating the predictor
output. An implementation of our predictor is available as
MATLAB source code from http://www.cs.tut.fi/˜hehu/
DREAM6-AML.html.
Feature Generation
Our prediction model uses rather simple linear operations and
distribution comparison in only one dimension. Thus, we cannot
expect the model to discover very complicated relations between
the input features. For this reason, we artificially expand the set of
features from the initial 5 fluorescence intensities and 2 scatter
features by taking all possible inverses (7 pcs) and second powers
(7 pcs) of single features and multiplications (21 pcs) and divisions
(42 pcs) of any combination of two features. Thus, the dimen-
sionality is increased from 7 to 84.
While overlearning seems not to be a problem in increasing the
dimensionality of the data, there are, however, some practical
problems. Namely, the average storage requirement of an 84-
dimensional data matrix of a single tube is between 4 and 32 Mb
depending on the number of events in the tube. When training
with all our data, this gets multiplied by 359, i.e., the number of
patients. This means that we have over 11 Gb of training data in
one of the tubes, which can be a problem depending not only on
the hardware setup but also on the type of forthcoming processing.
EDF Comparison
For each tube with a particular population of cells the next step
is to determine whether that population originates from an AML-
positive or healthy patient. This is done by using a two-sample
distribution comparison test such that we compare the estimated
distribution of the tested tube data against the distributions of both
AML-positive and healthy tubes, which have been estimated from
the training data. As a result, we get two similarity measures.
Multidimensional (in our case, 84-dimensional) density estima-
tion is known to be a difficult problem and the situation is further
complicated by the large amount of data. Our solution is to first
use LDA to map each sample x[R84 into 1-d:
x~ S^1zS^0
 {1
m^1{m^0ð Þx: ð1Þ
Here, S^1 and S^0 are the sample covariance matrices and m^1 and
m^0 are the sample means of both AML-positive and healthy
training samples, respectively.
Applying the LDA significantly reduces the amount of data and
allows us to use traditional 1-d methods for distribution
comparison. LDA allows us to use training data for finding the
linear mapping that best separates the AML-positive and healthy
populations in 1-d. Further, we do not need to have 11 Gb of free
memory in our computer, because we can easily calculate the
required mean vectors and covariance matrices iteratively one
patient at a time.
Figure 1. Block diagram of the AML predictor. First, for each tube, more features are generated from the seven dimensional flow cytometry
data by calculating all multiplications and divisions of any two basic features. Second, the data is mapped into 1-d with LDA and the EDF of the
resulting data is compared with the corresponding training EDFs of both AML-positive and healthy populations. Finally, the 14 EDF similarity scores
are combined by a logistic regression model that outputs a confidence value of the test patient being AML-positive. Similar to the reference EDFs,
LDA coefficients maximizing the separation between AML-positive and healthy populations as well as logistic regression coefficients are estimated in
a training phase.
doi:10.1371/journal.pone.0072932.g001
AML Prediction Using Sparse Logistic Regression
PLOS ONE | www.plosone.org 3 August 2013 | Volume 8 | Issue 8 | e72932
For 1-d two-sample distribution comparison, we calculate two
similarity measures e
(0)
t and e
(1)
t for each of the tubes
t~1,2, . . . ,7. The measures are based on the mean squared
error (MSE) between the EDFs of the tested tube data and the
one that has been trained for either healthy or AML-positive
tubes, respectively:
e
(c)
t ~
1
K
XK{1
k~0
Ft(x0zkDx){F
(c)
t (x0zkDx)
h i2
: ð2Þ
In the above equation, Ft(:) is the EDF of the tested tube data
after LDA mapping, and F
(c)
t are the corresponding EDFs of the
trained healthy tube (c~0) and the trained AML-positive tube
(c~1).
Instead of averaging the squared error in Equation 2 over the
complete EDFs, the error is only evaluated in K discrete points
uniformly chosen between points x0 and x0z(K{1)Dx. Our
validation tests show that we can use value as low as K~128
without degrading the classification performance. Thus, the
training EDFs are parametrized with 128 parameters, which frees
us from carrying the whole training data with us in the testing
phase. We choose x0 equal to the minimum of the training
samples and Dx such that x0z(K{1)Dx equals to the maximum
of the training samples.
In addition to the EDF MSE in Equation 2, also more
established distribution comparison methods were tested including
two-sample Crame´r-von Mises test [10], Kolmogorov-Smirnov test [11], and
Kullback-Leibler divergence [12]. Further, error measures like corre-
lation and MSE between the probability density functions
estimated with kernel smoothing density estimation were tested.
However, based on validation results, EDF MSE gave the best
classification performance.
Sparse Logistic Regression
Given a 14-dimensional feature vector e~(e(0)1 ,e
(1)
1 , . . . ,e
(0)
7 ,
e
(1)
7 )
T corresponding to the EDF error measures of each tube as
defined in Equation 2, our strategy is to use the logistic regression
model
p(e)~
1
1z exp (b0zb
T e)
ð3Þ
to estimate the probability p(e) of the patient being AML-positive.
Parameters b0 and b~(b1, . . . ,b14)
T are estimated from the
training data by maximizing the ‘1-penalized log-likelihood
X
ei[C0
log p(ei)z
X
ei[C1
log (1{p(ei)){lDDbDD1, ð4Þ
where l§0 is the regularization parameter and C0 and C1 are the
training sets of healthy and AML-positive patients, respectively.
Similar to that in linear regression using Least Absolute Shrinkage
and Selection Operator (LASSO) [9], the ‘1 penalty in Equation 4
results in the solution vector b being sparse such that only a few of
the coefficients are non-zero. Thus, the penalization works as an
implicit feature selector and any tube irrelevant from the diagnosis
point of view gets automatically dropped out from the model.
The role of the parameter l in Equation 4 is to control the
amount of regularization: the larger the value of l, the heavier the
regularization. For small values of l, the solution is close to the
maximum likelihood solution, while large values of l allow
restricted solutions only and push the coefficients towards zero. In
our case he value of l is automatically determined by cross-
validation.
Regularized generalized linear models including logistic regres-
sion models can be efficiently fit using a coordinate descent
algorithm proposed by Friedman et al. [13]. There is also a
MATLAB implementation available at http://www-stat.stanford.
edu/˜tibs/glmnet-matlab.
Reference Methods
In the forthcoming experiments section, we compare our
prediction model with the method by Vilar (http://www.ehu.es/
biologiacomputacional/team21_vilar) and the method by Biehl
et al. [5] (http://www.the-dream-project.org/story/code). In ad-
dition to these, we test two simple approaches as a reference: an ‘1
regularized logistic regression classifier and an LDA classifier with
plain mean values of the marker intensities (or scatter values) as
features.
The basic idea in Vilar’s predictor is similar to our method.
First, the distributions of data from AML-positive and healthy
training patients are compared against that of the tested patient for
each tube. Second, the resulting distribution similarity scores are
aggregated in a logistic regression model to derive an AML
confidence score between 0 and 1.
Vilar’s method doesn’t apply explicit dimension reduction for
the data to alleviate the problem of multidimensional density
estimation. Instead, the probability density of the 7-dimensional
tube data is approximated by using multiple lower dimensional
densities. These densities are constructed such that only one of the
fluorescence markers FL1, FL2, FL4, or FL5 is taken into account
in each density estimate while fluorescence marker FL3 (which is
always CD45 regardless of the tube) and forward and side scatters
are present in all of the low dimensional densities. This results in 4
different 4-dimensional distributions instead of one 7-dimensional.
In practice, these densities are approximated by histograms with
9 bins per dimension uniformly spaced in logarithmic scale
between 100:01 and 100:91 for all but the side scatter for which
the corresponding range is between 102:01 and 102:91. An
important feature, found out by our validation tests, is that any
sample outside the range of the histogram is considered an outlier
and discarded.
The comparison of the distributions in Vilars’s method is done
by using Kullback-Leibler divergence, i.e., relative entropy. Finally,
the entropies from each tube are combined by simply summing
together the relative entropies with the AML-positive population
and subtracting the entropies with healthy population. This total
entropy is then mapped with the logistic function to get the final
AML confidence score. In terms of the notation in Equation 3 this
means that e(c)t equals to the relative entropy against class c in tube
t and that the model coefficients are not estimated from training
data but fixed to b0~0 and b~({1,1,{1,1, . . . )
T .
Biehl’s method differs from our and Vilar’s by not trying to
estimate the full densities of the data. Instead, six quantities, mean,
standard deviation, skewness, kurtosis, median, and interquantile
range, are calculated for each marker and used as features. For
classification, Biehl uses Generalized Matrix Relevance Learning Vector
Quantization (GMLVQ). See [5] for details.
Results
This section presents the experimental results. First, we run a
CV test to assess and compare the performance of the previously
described five different methods: our original, Vilar’s, and Biehl’s
AML Prediction Using Sparse Logistic Regression
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methods, and ‘1 regularized logistic regression and LDA with
plain mean values of the marker intensities as features. In the result
tables and figures, these five methods are referred as EDF-MSE/
LR-LASSO, Vilar, Biehl et al., Mean/LR-LASSO, and Mean/LDA,
respectively. Second, we use all the available data to train the two
sparse logistic regression predictors and analyze the resulting
models.
Performance Assessment
We use the combined DREAM6 AML Challenge training and
test data consisting of 43 AML-positive and 316 healthy patients
and stratified 10-fold CV to benchmark the prediction models.
Thus, the validation result estimates the generalized model
performance when using about 90% of the data, i.e., 39 AML-
positive and 284 healthy patients, for training.
The ROC and PR curves resulting from the 10-fold CV are
shown in Figure 2 together with the AUC values for each
predictor. According to the AUC analysis tool StAR [14], only
LDA with mean features (AUC=0.88) differs from the other
methods (AUC& 0.98) with statistical significance. The StAR tool
is based on a two-sided Mann-Whitney test with a null hypothesis
that two AUC values are the same. A confidence level of a~0:05
was used in the significance test. Exact p-values are given in
Table 2.
Figure 3 shows how the test samples of the CV procedure
distribute into the predictors’ output space shown on the x-axis.
For visualization purposes, the output of Biehl’s method has been
rescaled by taking the power of 0:3. The y-axis shows the
histogram count. The title in each plot shows the corresponding
prediction method and a score value, which has been calculated as
a p-value that the AUCs of the ROC and PR curves have been
achieved by random chance. The p-value is given in negative log-
10 scale, i.e., the higher the better. See [15] for more details on
how the score has been derived.
Figure 4 shows the confusion matrices after thresholding the
predictor output. For logistic regression models, the threshold is
0:5. Biehl et al. don’t give a specific threshold for the output of the
GMLVQ classifier. In this case, we have chosen the threshold such
that the classification error in the training data is minimized.
Final Model
In this section, we use all the available 359 patients for training
the logistic regression classifier with ‘1 regularization. In the case
of the EDF MSE features the trained classifier can be written as
p(e)~
1
1z exp {4:5037z1:7980e(0)4 {1:0845e
(1)
4 {0:8694e
(1)
5 z0:0753e
(0)
6
  :ð5Þ
The remarkable notion is that the ‘1 regularization only selects
4 of the available 14 features. Further, only tubes 4, 5, and 6 are
included in the final model making tubes 1, 2, 3, and 7 non
informative from the diagnosis point of view.
Based on the absolute values of the logistic regression
coefficients in Equation 5, tube number 4 (see corresponding
markers from table 1) seems to be the most important one. Also
tube 5 has a substantial effect on the predictor output but only
when comparing against AML-positive (c~1) patients. Tube
number 6 has a similar effect on the healthy patients. However,
relatively small absolute coefficient value makes tube 6’s contri-
bution rather insignificant. Notice that comparing absolute
coefficient values makes sense because the similarity scores e(c)i
are normalized.
The full regularization path of the above case is shown in
Figure 5. The final model indicated by the black dashed line is
chosen by minimizing 10-fold CV error. The EDF distance
features from tube 4 are the first ones taken into the model when
the regularization is gradually decreased (i.e., DDbDD1 increases). This
further emphasizes the importance of tube 4. Interestingly, e
f0g
6 is
removed from the model right after the point of minimum CV
error suggesting that similar performance could be attained by
using only tubes 4 and 5. Notice, how the features from tube 1
approximately differ only by their sign. Further, the signs seem to
be the wrong way around: smaller distance to the healthy
population contributes towards classifying the patient as AML
positive and the vice versa. This is probably due to overlearning.
A similar analysis was run on the simpler model where the ‘1
regularized logistic regression was applied on the mean values of
each marker intensity or scatter reading. In this case, 17 of the 49
variables are automatically selected according to the CV error.
Figure 2. ROC and PR curves of 10 times repeated 10-fold CV test. The left panel shows the ROC and the right one the PR curves. The legend
shows the AUC values for different predictors. Except for LDA (green line), the differences in AUC values are statistically insignificant.
doi:10.1371/journal.pone.0072932.g002
( )
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Table 2. P-values of the significance test testing the difference of the AUC ROC values between each pair of prediction methods.
Method Biehl et al. Vilar Mean/LR-LASSO EDF-MSE/LR-LASSO Mean/LDA
Biehl et al. – – – – –
Vilar 0.1598 – – – –
Mean/LR-LASSO 0.1537 0.6809 – – –
EDF-MSE/LR-LASSO 0.2509 0.3486 0.6509 – –
Mean/LDA 0.0003 0.0004 0.0019 0.0040 –
The null hypothesis is that the AUC ROC values between two methods are the same. Given p-values are provided by the online ROC analysis tool StAR [14].
doi:10.1371/journal.pone.0072932.t002
Figure 3. Distribution of the test samples in predictor output space. Colors of the histogram bars indicate the true class label (gray color
denotes the overlapping parts). Titles in each plot tell the corresponding prediction method and a score value calculated as the negative log10 p-
value that the class separation has been attained by chance.
doi:10.1371/journal.pone.0072932.g003
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Figure 6 shows the coefficient values of the logistic regression
model. About half of the contribution in terms of ‘1 norm of the
coefficient vector comes from the four most significant markers,
which are CD34-PC5 from tube 6, side scatter from tube 5, and
CD16-PC5 and CD13-PE from tube 4.
More detailed information about the whole regularization path
of the above model is shown in Table 3. Here, we have picked the
best feature sets with given size along the regularization path. Set
sizes span from zero (bias term only) to 17, which is the model with
lowest CV error also shown in Figure 6. The markers in the list
have been sorted according to the absolute value of their
corresponding coefficient such that the most important feature is
always on top. The tube number of each marker is shown in the
subscript. Especially CD34-PC5, side scatter (SS), and CD16-PC5
seem to be included in the model from very early stage of the
regularization path.
The above analysis of the most important features supports the
discussion of [5], where seven markers were recognized as the key
features: forward scatter, side scatter, CD15-FITC, CD117-PE,
CD16-PC5, CD34-PC5, and CD10-PC7. All of these appear in
our final model (Figure 6) or on the regularization path (Table 3)
except the forward scatter measure. Missing forward scatter makes
sense because in [5] they show that the predictive power of the
forward scatter on linear scale relies on it’s higher moments,
especially standard deviation and skew, rather than on the
distribution average, which we use in our model.
In the model with marker means as features, scatters and CD45
intensities were not combined over the different tubes but the
mean values from each tube were taken as individual features.
Similar to that in Biehl’s method [5], also pooling of these
variables was tested. However, this decreased the validation
performance. To our knowledge, the intensity values of each
Figure 4. Confusion matrices. Distribution of the 359 test patients into false/true positives/negatives in a 10-fold CV test. Summary statistics are
given in the last rows/columns.
doi:10.1371/journal.pone.0072932.g004
Figure 5. Regularization path of the ‘1 regularized logistic
regression model with EDF MSE features. Coefficient values have
been plotted with respect to the ‘1 norm of the coefficient vector. The
black dashed line shows the final model chosen by cross-validation.
doi:10.1371/journal.pone.0072932.g005
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marker should be independent of the tube they are measured
from. One explanation for the above phenomenon is that there is
some kind of overlearning occurring when not combining the
corresponding markers from separate tubes.
Discussion
In this paper, we have described an automated method for
AML diagnosis from flow cytometry data. Our method uses the
combined DREAM6 AML Challenge training and test data for
which we run a cross-validation test in order to assess our
predictor. In addition, we compare our predictor against
predictors by Vilar and Biehl et al. [5], which were among the
best performing methods in the DREAM6 AML Challenge.
Experimental results show that there are no statistically significant
differences between the best performing prediction methods when
cross-validating them against the challenge data set of 43 AML-
positive and 316 AML-negative patients. Cross-validated classifi-
cation performances reach 99 %.
The key benefit in our predictor model is that, in the training
phase, the ‘1 regularized logistic regression model automatically
estimates the relevance of each flow cytometry tube or marker.
Only a subset of the available features (3 of the 7 tubes with the
EDF MSE features or 17 of the 49 markers with the mean
intensity features) are selected still reaching a performance
equivalent to the alternative methods. Thus, in a testing phase,
only a fraction of the usual flow cytometry measurements are
needed. Another beneficial feature in our model is that it has
virtually no parameters that would need manual tuning. Instead,
the regularization parameter l is automatically chosen by cross-
validation and the number of EDF bins K is, by construction,
robust against changes in the data. This is in contrast, e.g., with
Vilar’s algorithm where even a small change in the dimensions of
the density histogram was noticed to result in deterioration of the
cross-validation performance by several percentage units.
The proposed framework contains two alternatives for feature
extraction: The simple version with mean intensity features
(termed Mean/LR-LASSO in the experiments) and the complex
version using the mean squared errors between the EDFs (termed
EDF-MSE/LR-LASSO). Experiments show that there is no
significant difference in performance between the two alternatives.
In fact, all the studied methods are almost perfect in terms of
accuracy, so the only reasonable conclusion is to favor the simplest
solution. Many studies emphasize that simplicity should be the
guiding principle in the design of classifiers; see for example
[16,17]. In [17], the author describes this reasoning as follows:
‘‘…simple methods typically yield performance almost as good as
more sophisticated methods, to the extent that the difference in
performance may be swamped by other sources of uncertainty…’’.
Along these lines, we believe that the proposed use of regularized
logistic regression also has the best generalization for future
samples, due to its simplicity. In particular, according to the
experiments of this paper, the method of choice should use simple
mean intensity features (Mean/LR-LASSO) instead of the
complex EDF-MSE features.
However, we do believe that the more complex EDF-MSE
features has potential to simplify the classifier structure even
Figure 6. Logistic regression model coeffients with average normalized scatter/intensity values as features. Only 17 of the 49
coefficients get a non-zero value due to ‘1 regularization. Numbers in the subscript indicate the tube number.
doi:10.1371/journal.pone.0072932.g006
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Table 3. Best subsets of certain size along the regularization path of the logistic regression classifier with average marker
intensities as features.
Set size 0 1 2 3 4 5
Markers CD34-PC56 CD34-PC56 CD34-PC56 CD16-PC54 SS6
SS6 SS6 CD34-PC56 CD16-PC54
CD15-FITC4 SS6 CD34-PC56
CD15-FITC4 CD38-PC76
CD56-PC74
DDbDD1 0.00 0.05 0.16 0.29 0.92 1.74
CV err. 0.120 0.120 0.120 0.120 0.092 0.053
Set size 6 7 8 9 10 11
Markers SS6 SS6 SS6 SS6 SS6 SS6
CD16-PC54 CD16-PC54 CD16-PC54 CD16-PC54 CD16-PC54 CD16-PC54
CD34-PC56 CD34-PC56 CD34-PC56 CD34-PC56 CD34-PC56 CD34-PC56
CD38-PC76 CD38-PC76 CD38-PC76 CD38-PC76 CD38-PC76 CD38-PC76
CD56-PC74 CD56-PC74 CD56-PC74 CD56-PC74 CD56-PC74 CD56-PC74
CD117-PE6 CD117-PE6 CD13-PE4 CD13-PE4 CD13-PE4 CD13-PE4
CD13-PE4 CD117-PE6 CD33-PC76 CD33-PC75 CD33-PC75
CD33-PC75 CD117-PE6 CD15-FITC4 CD15-FITC4
CD15-FITC4 CD10-PC77 CD10-PC77
CD117-PE6 CD117-PE6
CD19-PE7
DDbDD1 2.40 2.50 3.11 3.57 4.31 4.41
CV err. 0.033 0.033 0.025 0.022 0.019 0.019
Set size 12 13 14 15 16 17
Markers SS6 SS6 CD34-PC56 CD34-PC56 CD34-PC56 CD34-PC56
CD16-PC54 CD34-PC56 SS6 SS6 SS6 SS6
CD34-PC56 CD16-PC54 CD16-PC54 CD16-PC54 CD16-PC54 CD16-PC54
CD56-PC74 CD56-PC74 CD13-PE4 CD13-PE4 CD13-PE4 CD13-PE4
CD38-PC76 CD13-PE4 CD56-PC74 CD56-PC74 CD56-PC74 CD15-FITC4
CD13-PE4 CD38-PC76 CD38-PC76 CD38-PC76 CD15-FITC4 IgG1-PC71
CD33-PC75 CD33-PC75 CD33-PC75 CD33-PC75 CD33-PC75 CD33-PC75
CD10-PC77 CD10-PC77 CD15-FITC4 CD15-FITC4 IgG1-PC71 CD56-PC74
CD15-FITC4 CD15-FITC4 IgG1-PC71 IgG1-PC71 CD38-PC76 IgG1-PE1
CD19-PE7 CD19-PE7 CD10-PC77 CD10-PC77 CD10-PC77 CD38-PC76
CD117-PE6 CD117-PE6 CD19-PE7 CD19-PE7 IgG1-PE1 CD117-PE6
CD5-FITC7 CD5-FITC7 CD117-PE6 CD117-PE6 CD117-PE6 CD10-PC77
IgG1-PC71 CD5-FITC7 CD5-FITC7 CD5-FITC7 CD5-FITC7
SS5 SS5 CD19-PC52 Lambda-PE2
IgG1-PE1 CD8-PC53 CD8-PC53
Lambda-PE2 IgG1-PC51
CD19-PC52
DDbDD1 4.66 4.87 5.95 6.02 7.21 8.49
CV err. 0.019 0.019 0.019 0.017 0.014 0.011
Markers in the list have been sorted according to the absolute value of their corresponding coefficient such that the most important feature is always on top. CV err.
indicates the 10-fold CV classification error when using regularization parameter l corresponding to the ‘1 norm of the coefficient vector as given in DDbDD1 . The lowest CV
error (0:011) is attained with the 17 markers shown in Figure 6.
doi:10.1371/journal.pone.0072932.t003
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further, allowing even better generalization performance for future
samples. In the experiments, the complex feature extraction model
trained with all data uses slightly more features than the simple
feature extraction (21 versus 17), but when trained with the subset
defined as training data in the DREAM6 challenge, the resulting
model uses only two tubes, i.e., 14 features. One reason for the
fluctuation in the selected features is seen in the model of Eq. (5),
where only one of the two similarity measures e
(0)
t and e
(1)
t is used
for tubes t~5 and t~6. The obvious choice would be to exploit
them both, which happens when trained with the training subset of
DREAM6. We plan to investigate this further by generalizing the
method to use Group LASSO for logistic regression [18], which
allows the feature selection in groups.
In comparison to the binary diagnosis task studied in this paper,
a more clinically relevant and computationally more challenging
question is how to accurately predict the specific subtype of AML.
For example, the World Health Organization has issued a
classification of AML subtypes that aims to be more clinically
relevant by containing prognostic value and provides guidelines for
treatment [2]. Data driven methods could provide accurate and
objective classification to existing subgroups, by solving a multi
class classification problem, and class discovery methods could be
used to uncover new homogeneous subtypes from data. However,
to address these questions, more extensive data collections need to
be generated. By using multi class logistic regression classifier, our
methods could directly be extended to multi class classification
problem and it would be of interest to see whether the tubes and
features that were deemed uninformative in context of AML
classification would in fact contain information about differences
between AML subtypes and, further, which tubes give information
about specific AML subtypes. This type of approach has
previously provided good results, e.g., in studying human brain
activity created by different types of visual stimuli [19].
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